GSK-481 | Interleukin Related interleukin-related.com

Product Name :
GSK-481

Search keywords :
GSK481

drugId :
null

Target Vo:
Receptor-interacting serine/threonine-protein kinase 1

Target Vo Short Name :
RIP1

Moa_Name:
Receptor-interacting serine/threonine-protein kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxosmithkline Plc

Active Indication_Name:
Inflammation

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TRITC-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
PSD95 Antibody
Neomycin Antibody (YA907): Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts